Chordate Medical Holding AB (CMH) — Strategic Asset Allocation Index
Chordate Medical Holding AB (CMH) has a Strategic Asset Allocation Index of 2.0% as of June 2023. Strategic assets (PP&E of Skr584.25K plus long-term investments of Skr-) total Skr584.25K, measured against net assets of Skr29.87 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Chordate Medical Holding AB (CMH) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Chordate Medical Holding AB Strategic Asset Allocation Index (2019–2022)
This chart shows how Chordate Medical Holding AB's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the index stands at 2.0%, representing strategic assets of Skr584.25K against net assets of Skr29.87 Million SEK. For live market cap and overall valuation, see CMH market cap overview.
Annual Strategic Asset Allocation Index for Chordate Medical Holding AB (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Chordate Medical Holding AB from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Chordate Medical Holding AB book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 6.1% | Skr675.45K | Skr675.45K | Skr- | Skr11.07 Million | ▲ +4.7 pp |
| 2021 | 1.4% | Skr546.08K | Skr546.08K | Skr- | Skr38.95 Million | ▼ -1.7 pp |
| 2020 | 3.1% | Skr806.20K | Skr806.20K | Skr- | Skr25.64 Million | ▼ -5.8 pp |
| 2019 | 9.0% | Skr986.78K | Skr986.78K | Skr- | Skr10.98 Million | — |